Compare BioNano Genomics Inc (BNGO) vs Impinj Inc (PI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Impinj Inc — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.77M), while Impinj Inc trades at $180 (market cap $5.49B). The key difference: Impinj Inc is far larger — about 398.7× BioNano Genomics Inc's market cap, and Impinj Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | PI | |
|---|---|---|
Market Cap | $13.77M | $5.49B |
Sector | Health | Technology |
52-Week High | $4.92 | $241.91 |
52-Week Low | $1.06 | $91.34 |
Enterprise Value | $16.38M | $5.62B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Impinj (PI) trades at $179.58, up 1.89% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $186. The stock shows strong revenue growth and recent earnings beats, but faces profitability challenges with negative net income margins. Recent news highlights institutional buying and record Q2 2026 results, driving positive sentiment.
Outlook: Upside potential exists from analyst targets and RFID market growth, but risks include persistent losses and high valuation multiples. Investment appeal hinges on margin improvement and execution against guidance, with current levels near resistance requiring careful entry timing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Impinj Inc
Impinj, Inc. is a leading provider of RAIN RFID (radio-frequency identification) solutions. The company's platform includes endpoints (tag chips), connectivity devices (readers and gateways), and software, enabling businesses to wirelessly identify, locate, and authenticate everyday items. Impinj's technology is crucial for applications in retail, supply chain management, healthcare, and logistics, helping businesses to automate inventory, track assets, and improve operational efficiency.
Read more on PI →
